insights_auto
Why is PTX up 6.00%?
Dive Deeperchevron_right
PTX:ASX
Prescient Therapeutics Ltd
A$0.053
arrow_upward
+6.00%(+0.0030) 1D
Nov 3, 4:00:00 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.05
High
A$0.05
Low
A$0.05
Mkt. cap
60.62M
Avg. vol.
671.92K
Volume
49.21K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
Open
A$0.05
High
A$0.05
Low
A$0.05
Mkt. cap
60.62M
Avg. vol.
671.92K
Volume
49.21K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
News stories
From web sources and news partners
Investing.com
·
38 minutes ago
MediWound’s EscharEx Strategy May Be Ahead of the Game as FDA Puts Chronic Wounds in Focus (Nasdaq: MDWD)
www.marketscreener.com
·
1 hour ago
NYSE-Affiliated Venue for Tokenization Adds Transfer Agents: NYSE Content Update
Seeking Alpha
·
3 minutes ago
Most shorted stocks on Wall Street
Barchart.com
·
2 hours ago
Upstart (NASDAQ:UPST) posts better-than-expected sales in Q3 2026, stock soars
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com